↓ Skip to main content

Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis

Overview of attention for article published in Arthritis Research & Therapy, May 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
5 X users
googleplus
1 Google+ user

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
Published in
Arthritis Research & Therapy, May 2012
DOI 10.1186/ar3834
Pubmed ID
Authors

Marian L Burr, Sebastien Viatte, Marwan Bukhari, Darren Plant, Deborah P Symmons, Wendy Thomson, Anne Barton

Abstract

The utility of reassessing anti-cyclic citrullinated peptide (anti-CCP) antibody status later in disease in patients presenting with early undifferentiated inflammatory polyarthritis, particularly in those who test negative for both anti-CCP and rheumatoid factor (RF) at baseline, remains unclear. We aimed therefore to determine the stability of CCP antibody status over time and the prognostic utility of repeated testing in subjects with early inflammatory polyarthritis (IP).

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Colombia 1 3%
Unknown 34 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 17%
Student > Master 5 14%
Researcher 3 8%
Other 3 8%
Student > Bachelor 2 6%
Other 6 17%
Unknown 11 31%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Agricultural and Biological Sciences 2 6%
Psychology 1 3%
Other 2 6%
Unknown 14 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2017.
All research outputs
#7,943,506
of 25,497,142 outputs
Outputs from Arthritis Research & Therapy
#1,601
of 3,395 outputs
Outputs of similar age
#53,532
of 176,340 outputs
Outputs of similar age from Arthritis Research & Therapy
#24
of 73 outputs
Altmetric has tracked 25,497,142 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,395 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.